At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 68 enrolled
Drug / intervention
AN2728 ointment, 2% +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multicenter, Randomized, Double-Blind, 12-Week Study Of The Safety And Efficacy Of AN2728 Versus AN2728 Vehicle In The Treatment Of Patients With Mild-To-Moderate Plaque-Type Psoriasis
In Brief
A Phase 2 clinical trial evaluating AN2728 ointment, 2% and Ointment Vehicle for Psoriasis. Completed, enrolled 68 participants across 10 sites.
Detailed Summary
The purpose of this study is to determine whether AN2728 topical ointment is a safe and effective treatment for mild-to-moderate plaque-type psoriasis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPsoriasis
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJan 2011
First PostedFeb 2011
Primary CompletionJun 2011
TodayJul 2026
First PostedFeb 21, 2011
Enrollment StartJan 26, 2011
Primary CompletionJun 6, 2011
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 15.4 years ago
Interventions
AN2728 ointment, 2%drug
AN2728 ointment, 2%, applied twice daily for 12 weeks
Ointment Vehicledrug
Ointment Vehicle, applied twice daily for 12 weeks